Login
Navigate Fool.com
Will BIND beat
the market?

BIND Therapeutics, Inc. (NASDAQ: BIND)

Community Rating: 5 Stars: The Best

9.23 0.25 (2.78%)

Quote as of

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.00
Previous Close $8.98
Daily Range $9.00 - $9.34
52-Week Range $8.00 - $15.89
Market Cap $151.8M
P/E Ratio -4.10
Dividend (Yield) $0.00 (0.0%)
Volume 63,182
Average Daily Volume 169,792
Current FY EPS -$1.41

How do you think BIND
will perform against the market?

Top BIND Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted September 23, 2013

A little leap of faith here, courtesy of Portefeuille who instructed me to buy 400 shares of this stub at 14.3 after it traded down on the day of its IPO. BIND has an impressive provenance, having bee … More

1 Replies Reply Report this Post
 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary Rss Feed

Biotech Stocks to Watch Today: AbbVie, Bind Therapeutics, MannKind, and Shire

Today's top stories in biotech and health care.

Sector Update: Healthcare Stocks Slightly Higher; BIND Therapeutics Drops Partnership with Amgen on

Sector Update: Healthcare Stocks Slightly Higher; BIND Therapeutics Drops Partnership with Amgen on Cancer Treatment

Sector Update: Healthcare

Why BIND Therapeutics Inc. Shares Soured

BIND shares tumble after tthe company announces the loss of a key piece of the puzzle.

Insiders at Synageva BioPharma and Bind Therapeutics Buy Shares

Plus, there were purchases at Accuride and Weatherford International.

Insiders at Synageva BioPharma and Bind Therapeutics Buy Shares

BIND Therapeutics Announces Closing of Initial Public Offering

See More BIND News...

Sector

Industry

BIND Therapeutics, Inc. (BIND) Description

BIND Therapeutics, Inc. Website: http://www.bindtherapeutics.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks